Reported 15 days ago
CVS Health has seen a remarkable 76% increase in its share price in 2023, driven by better-than-expected financial results despite ongoing challenges in its Medicare Advantage unit. The stock is trading at a lower valuation than the industry average, making it potentially undervalued. With plans to focus on improving profit margins and a diverse healthcare ecosystem, CVS's long-term outlook appears promising, appealing to investors looking for growth in the healthcare sector.
Source: YAHOO